Nuclear Medicine Unit,
C.G. Mazzoni Hospital,
Ascoli Piceno (IT)
 | chiara.fuccio@libero.it; chiara.fuccio@sanita.marche.it |
Chiara Fuccio , born in 1981, in Italy. In 2006, degree in Medicine and Surgery at the University of Bologna (Italy); dissertation on: “ Functional Imaging of Neuroendocrine Tumours: the role of 18F-DOPA PET/CT”.
In 2011, post-graduate school of Nuclear Medicine at the University of Bologna (Italy); dissertation on “Role of 11C-choline PET/CT in the re-staging of prostate cancer patients with biochemical relapse and negative results at Bone Scintigraphy”.
Medical Assistant in Nuclear Medicine at Fondazione Salvatore Maugeri, Pavia, Italy from August 2011 to July 2014.
Currently, medical assistant in Nuclear Medicine at C.G. Mazzoni Hospital, Ascoli Piceno, Italy.
Practical experience acquired in Conventional Nuclear Medicine and PET (oncology, neurology and other applications using 18F-FDG and other tracers such as: 11C- and 18F- fluorocholine, 11C- methionine, 68Ga- DOTANOC, 18F-DOPA,11C-Acetate, 67Ga- Citrate, 11C-HED, 18F- NaF.
Fields of interest: PET/CT in the evaluation of prostate cancer, renal cancer and bladder cancer; PET/CT and radiation therapy.
Member of: Italian Society of Nuclear Medicine (AIMN).
In 2011, post-graduate school of Nuclear Medicine at the University of Bologna (Italy); dissertation on “Role of 11C-choline PET/CT in the re-staging of prostate cancer patients with biochemical relapse and negative results at Bone Scintigraphy”.
Medical Assistant in Nuclear Medicine at Fondazione Salvatore Maugeri, Pavia, Italy from August 2011 to July 2014.
Currently, medical assistant in Nuclear Medicine at C.G. Mazzoni Hospital, Ascoli Piceno, Italy.
Practical experience acquired in Conventional Nuclear Medicine and PET (oncology, neurology and other applications using 18F-FDG and other tracers such as: 11C- and 18F- fluorocholine, 11C- methionine, 68Ga- DOTANOC, 18F-DOPA,11C-Acetate, 67Ga- Citrate, 11C-HED, 18F- NaF.
Fields of interest: PET/CT in the evaluation of prostate cancer, renal cancer and bladder cancer; PET/CT and radiation therapy.
Member of: Italian Society of Nuclear Medicine (AIMN).
